Silva EP, Vasconcelos
DFP, Marques MR, Dias da Silva MA, Manzi FR, Barros SP. Intermittent administration of parathyroid hormone
improves the repairing process of rat calvaria defects: A histomorphometric and
radiodensitometric study. Med Oral Patol Oral Cir Bucal. 2015 Jul 1;20 (4):e489-93.
doi:10.4317/medoral.20412
http://dx.doi.org/doi:10.4317/medoral.20412
|
1.
Cunha MJ, Esper LA, Sbrana MC, de Oliveira PG, do Valle AL, de Almeida AL.
Effect of low-level laser on bone defects treated with bovine or autogenous
bone grafts: in vivo study in rat calvaria. Biomed Res Int. 2014;2014:104230. |
|
|
|
|
|
2.
Ahn SH, Kim CS, Suk HJ, Lee YJ, Choi SH, Chai JL, et al. Effect of
recombinant human bone morphogenetic protein-4 with carries in rat calvarial
defects. J Periodontol. 2003;74:787-97. |
|
|
|
|
|
3.
Blom EJ, Klein-Nulend J, Yin L, van Waas MA, Burger EH. Transforming growth
factor, incorporated in calcium phosphate cement stimulates
osteotransductivity in rat calvarial bone defects. Clin Oral Implants Res.
2001:12:609-16. |
|
|
|
|
|
4.
Marden LJ, Fan RS, Pierce GF, Reddi AH, Hollinger JO. Platelet-derived growth
factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic
protein, in rat craniotomy defects. J Clin Invest. 1993;92:2897-905. |
|
|
|
|
|
5.
Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic actions of
parathyroid hormone on bone. Endocr Rev. 1993;14:690-709. |
|
|
|
|
|
6.
Barros SP, Silva MAD, Somerman MJ, Nociti FH. Parathyroid hormone protects
against periodontitis-associated bone loss. J Dent Res. 2003:82;791-5. |
|
|
|
|
|
7.
Marques MR, da Silva MA, Manzi FR, Cesar-Neto JB, Nociti FH, Barros SP.
Effect of intermittent PTH administration in the periodontitis-associated
bone loss in ovariectomized rats. Arch Oral Biol. 2005;50:421-9. |
|
|
|
|
|
8.
Vasconcelos DFP, Marques MR, Benatti BB, Barros SP, Nociti Jnior FH, Novaes
PD. Intermittent parathyroid hormone administration improves periodontal
healing in rats. J Periodontol. 2014;85:721-8. |
|
|
|
|
|
9.
Jilka R, Weintein RS, Belido T, Roberson P, Parfitt AM, Manolagas SC.
Increased bone formation by prevention of osteoblast apoptosis with
parathyreoid hormone. J Clin Invest. 1999;104:439-46. |
|
|
|
|
|
10.
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al.
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in
postmenopausal women with osteoporosis. N Engl J Med. 2001;10:1434-41. |
|
|
|
|
|
11.
Andreassen TT, Fledelius C, Ejersted C, Oxlund H. Increases in callus
formation and mechanical strength of healing fractures in old rats treated
with parathyroid hormone. Acta Orthop Scand. 2001;72:304-7. |
|
|
|
|
|
12.
Seebach C, Skripitz R, Andreassen TT, Aspenberg P. Intermittent parathyroid
hormone (1-34) enhances mechanical strength and density of new bone after
distraction osteogenesis in rats. J Orthop Res. 2004;22:472-8. |
|
|
|
|
|
13.
Stancoven BW, Lee J, Dixon DR, McPherson JC, Bisch FC, Wikesj UM, et al.
Effect of bone morphogenetic protein-2, demineralized bone matrix and
systemic parathyroid hormone (1-34) on local bone formation in a rat calvaria
critical-size defect model. J Periodontal Res. 2013;48:243-51. |
|
|
|
|
|
14.
Andreassen TT, Cacciafesta V. Intermittent parathyroid hormone treatment
enhances guided bone regeneration in rat calvarial bone defects. J Craniofac
Surg. 2004;15:424-7. |
|
|
|
|
|
15.
Pereira Vasconcelos DF, Dias da Silva MA, Rocha Marques M, Gibilini C,
Cardoso Guimares Vasconcelos AC, Pereira Barros S. Effects of simultaneous
nicotine and alcohol use in periodontitis progression in rats: a
histomorphometric study. J Clin Exp Dent. 2013;5:e95-9. |
|
|
|
|
|
16.
Bosch C, Melsen B, Vargervik K. Importance of the critical-size bone defect
in testing bone-regenerating materials. J Craniofac Surg. 1998;9:310-6. |
|
|
|
|
|
17.
Bauer DC, Garnero P, Bilezikian JP, Greenspan SL, Ensrud KE, Rosen CJ, et al.
Short-term changes in bone turnover markers and bone mineral density response
to parathyroid hormone in postmenopausal women with osteoporosis. J Clin
Endocrinol Metab. 2006;91:1370-5. |
|
|
|
|
|
18.
Winarno AS, Kyvernitakis I, Hadji P. Successful treatment of 1-34 parathyroid
hormone (PTH) after failure of bisphosphonate therapy in a complex case of
pregnancy associated osteoporosis and multiple fractures. Z Geburtshilfe
Neonatol. 2014;218:171-3. |
|
|
|
|
|
19.
Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment
with parathyroid hormone. J Bone Joint Surg Br. 2001;83:437-40. |
|
|
|
|
|
20.
Shirota T, Tashiro M, Ohno K, Yamaguchi A. Effect of intermittent parathyroid
hormone (1-34) treatment on the bone response after placement of titanium
implants into the tibia of ovariectomized rats. J Oral Maxillofac Surg.
2003;61:471-80. |
|
|
|
|
|
21.
Schmitz JP, Hollinger JO. The critical size defect as an experimental model
for craniomandibulofacial nonunions. Clin Orthop Relat Res. 1986;205:299-308. |
|
|
|
|
|
22.
Aalami OO, Nacamuli RP, Lenton KA, Cowan CM, Fang TD, Fong KD, et al.
Applications of a mouse model of calvarial healing: differences in
regenerative abilities of juveniles and adults. Plast Reconstr Surg.
2004;114:713-20. |
|
|
|
|
|
23.
Whitfield JF, Morley P, Ross V, Isaacs RJ, Rixon RH. Restoration of severely
depleted femoral trabecular bone in ovariectomized rats by parathyroid
hormone-(1-34). Calcif Tissue Int. 1995;56:227-31. |
|
|
|
|
|
24.
Augustine M, Horwitz MJ. Parathyroid hormone and parathyroid hormone-related
protein analogs as therapies for osteoporosis. Curr Osteoporos Rep.
2013;11:400-6. |
|
|
|
|
|
25.
Lucisano MP, Nelson-Filho P, Morse L, Battaglino R, Watanabe PC, Silva RA, et
al. Radiodensitometric and DXA analyses for the measurement of bone mineral
density after systemic alendronate therapy. Braz Oral Res. 2013;27:252-7. |
|
|
|
|
|
26.
Rowshan HH, Parham MA, Baur DA, McEntee RD, Cauley E, Carriere DT, et al.
Effect of intermittent systemic administration of recombinant parathyroid
hormone (1-34) on mandibular fracture healing in rats. J Oral Maxillofac
Surg. 2010;68:260-7. |
|
|
|
|
|
27.
Erdogan O, Incki KK, Benlidayi ME, Seydaoglu G, Kelekci S. Dental and
radiographic findings as predictors of osteoporosis in postmenopausal women.
Geriatr Gerontol Int. 2009;9:155-64. |
|
|
|
|
|
28.
Garnero P, Bauer DC, Mareau E, Bilezikian JP, Greenspan SL, Rosen C, et al.
Effects of PTH and alendronate on type I collagen isomerization in
postmenopausal women with osteoporosis: the PaTH study. J Bone Miner Res.
2008;23:1442-8. |
|
|
|
|